Consorcium MEMBERS

1. L. Adamson, MD, Karolinska Institutet, Stockholm, Sweden.
2. J. Barrett, MD PhD, National Institutes of Health, Bethesda, MD, USA.
3. A. Berrebi, MD, Kaplan Medical Center, Rehovot, Israel.
4. C. Bollard, Assoc.Prof., Center for Cell and Gene Therapy, Houston, USA.
5. F.M. Brehar, MD PhD, Emergency Clinical Hospital, Bucharest, Romania.
6. G. M. Butenko, PhD, Institute of Genetic and Regenerative Medicine, Academy of Science, Ukraine.
7. E. Chernykh, MD, PhD, Russian Academy of Medical Sciences, Siberian Branch, Novosibirsk, Russia.
8. A. Darinskas, PhD, Lithuania Health Science University, Kaunas, Lithuania.
9. M. Edinger, MD PhD, University Hospital Regensburg, Regensburg, Germany.
10. V. Ehemann, MD PhD, Pathologisches Institut, Universitat Heidelberg, Heidelberg, Germany.
11. H. Einsele, MD PhD, Department of Hematology, University of Wuerzburg, Wuerzburg, Germany.
12. A. Facciabene, PhD, School of Medicine, University of Pennsylvania, PA, U.S.A.
13. T. Felzmann, MD PhD, Children´s Cancer Research Institute, Vienna, Austria.
14. M. Flower, CaridianBCT, Lakewood, CO, USA.
15. M. Foti, PhD, Universita Degli Studi di Milano-Bicocca, Milano, Italy.
16. Ch. Gabriel, MD, Blutzentrale Linz - Austrian Cluster for Tissue Regeneration, Austria
17. K. Giannopoulos, MD PhDMedical University at Lublin, Lublin, Poland.
18. Y. Godfrin, PhD, ERYTECH Pharma, Lyon, France.
19. E.A.J.M. Goulmy, Department of Immunohematology and Blood Transfusion, Leiden, The Netherlands.
20. D. Hart, MB Dphil, Dendritic Cell Biology and Therapeutics, University of Sydney, Sydney, Australia.
21. M. Imhof, PhD, Life Research Technologies, Vídeň, Austria.
22. N. Karandikar, MD, Department of Pathology and Immunology, University of Texas Southwestern Medical Center, Dallas, TX, U.S.A.
23. A. Keating, PhD, Department of Cell Therapy, University of Toronto, Toronto, Canada.
24. V.A. Kozlov, MD, PhD Research Institute for Clinical Immunology, Russian Academy of Medical Sciences, Siberian Branch, Novosibirsk, Russia.
25. B.J. Kroesen, PhD Dept. Pathology and Medical Biology
University Medical Center Groningen, Groningen, The Netherlands.
26. P. Kudela, PhD, BIRD-C Gmbh&CoKG, The Bacterial Ghost Company, Vienna, Austria.
27. G. KvalheimMD, PhD, Department of Cellular Therapy, Radiumhospitalet, Oslo University, Oslo, Norway.
28. C. Leclerc, PhD, Head of Unit Biologie des Regulations Immunitaires, Institut Pasteur, Paris, France.
29. K.H.G. Mills, PhD, School of Biochemistry and Immunology, Trinity College, Dublin, Ireland.
30. J. Pinxteren, PhD, Regenesys, Belgium.
31. D. Powell, PhD, University of Pennsylvania, Philadelphia, PA, USA.
32. I. Puzanov, MD PhD, Vanderbilt-Ingram Cancer Center, Nashville, TN, U.S.A.
33. H. Redl, PhD, Ludwig Boltzmann Institute for Experimental and Clinical Traumatology, Austrian Cluster for Tissue Regeneration
Vienna, Austria
34. K. Rezvani, MD PhD, Imperial College, Hematology Departent, Hammersmith Hospital, London, United Kingdom.
35. J. Rosocha, MD PhD, Univerzita P.J.Šafárika, Košice, Slovakia.
36. S. Rossi, Cell Therapy, CaridianBCT, Denver, CO, USA.
37. G. Safrany, MD PhD , National Research Institute, Budapest, Hungary.
38. V.E.J.C. Schijns, PhD, Wageningen University, Wageningen, The Netherlands.
39. M. Schmitt, MD PhD, Universitat Rostock, Rostock, Germany.
40. S. Slavin, MD PhD, International Center for Cell Therapy and Cancer Immunotherapy Weizman Center, Tel Aviv, Israel.
41. R. Sorg, PhD, Heinrich Heine University Hospital, Duesseldorf, Germany.
42. F.K. Stevenson, PhD, University of Southampton, Souhtampton, United Kingdom.
43. V. van Tendeloo, PhD, Center for Cellular Therapy and Regenerative Medicine, University of Antverp, Antverpy, Belgie.
44. U. Toh, MD, Kurume University School of Medicine, Fukuoka, Japan.
45. E. Yakushenko, Research Institute of Clinical Immunology SB RAMS, Novosibirsk, Russia.
46. D. Zheng, PhD, Chinese Academy of Medical Sciences, Beijing, China.
47. M.B. Zocca, MSc PhD, DanDrit Biotech, Kopenhagen, Denmark